6 semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial GLP-1 weight-loss drugs may also

Instead, they all had significant knee osteoarthritis

REDEFINE Phase 3 clinical program evaluating cagrilintide alone and with semaglutide 3,400+ Participants in the REDEFINE 1 trial across multiple countries Questions No, cagrilintide is not yet FDA approved

Another study concluded that GLP-1s didnt affect psychiatric symptoms in 29 people with bipolar disorder or depression

This is why aggressive, fast-paced detoxification is highly contraindicated for complex chronic illness patients

Andrew Huberman: But yeah, they make

Milosavljevic V, Jamroz E, Gagic M et al (2020) Encapsulation of doxorubicin in furcellaran/chitosan nanocapsules by layer-by-layer technique for selectively controlled drug delivery